Life Science Industry Insights
At Kymanox®, we share expert insights to help life science teams navigate product development, regulatory strategy, quality, and manufacturing challenges. Our thought leadership covers advanced therapies, combination products, medical devices, and operational readiness — offering practical guidance to accelerate innovation and bring safe, effective products to market.
- All
- Blog
- Industry Articles
- Press Release
Kymanox Announces the Appointment of Evan Edwards to Chief Executive Officer and the Transition of Stephen M. Perry to Executive Chairman
Planned Leadership Transition Positions Kymanox for Continued Growth and Innovation…
How to Build a Scalable QMS from Clinic to Commercial
Practical roadmap for life sciences companies seeking to scale their Quality Management Systems alongside product development….
FDA QMSR Alignment to ISO 13485: Key Changes Ahead
While the industry has been anticipating alignment with ISO 13485 for years, the final rule brings both clarity and new…
Introduction to ISO 23908
Ensure your device or combination product complies with the recent revisions to the Sharps Injury Protection standard (ISO 23908)…
How Nose-to-Brain Delivery Is Revolutionizing CNS Therapeutics
Learn how N2B devices, formulations, and FDA precedents are transforming CNS therapeutics….
Drug Delivery Device Landscape for Nasal Products
This analysis draws from a comprehensive evaluation of more than 25 nasal drug delivery device manufacturers and provides a practical…
Selecting the Right CDMO
A systematic, repeatable CDMO selection methodology…
Product Design Strategy
Mastering the Path from Product Design to Commercial Manufacturing…
Jabil and Kymanox Announce Collaboration to Deliver End-to-End Development, Regulatory, and Manufacturing Solutions for Pharma, Biotech
This collaboration aims to support drug-device combination products and complex life science innovations throughout their entire lifecycle….
Navigating Regulatory Bridging Strategies for Nasal Product Development
Nasal drug products are among the most complex combination products to develop—often requiring a careful balance between formulation, device, and…
Implementation of Continued Process Verification Program for Post-Market Compliance & Product Success
Key steps for a successful CPV program implementation using a phased-approach for both legacy and approved products, as well as…
Digital Twins in Biomanufacturing
Learn what digital twins are, follow a practical 12-month implementation roadmap, understand scaling-up versus scaling-out strategies, and discover how to…
Navigating the Last Mile
Best Practices for Successful Delivery Device Development for Advanced Therapies…
Discussion on Anti-Obesity Treatments (GLP-1)
How GLP-1s Are Transforming Healthcare Treatments…
Kymanox Partners with Blue Mountain to Deliver Enterprise Asset Management
Kymanox is proud to announce a new non-exclusive partnership with Blue Mountain, the leader in Enterprise Asset Management software….
Kymanox and SHL Medical Enter a Non-Exclusive Strategic Partnership Agreement to Support Delivery of Modern Medicines
Collaboration Provides Streamlined Communications and Efficiencies to Pharmaceutical and Biotech Manufacturers Commercializing SHL Drug Delivery Solutions …
FDA’s New Guidance on Essential Drug Delivery Outputs
Key Highlights From the FDA Draft Guidance “Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological Products”…
Kymanox Announces Facility Expansion to Enhance CGxP Space and Laboratory Service Offerings
The company is poised to create additional life science jobs and advancement opportunities for the team…
Kymanox Announces Evan Edwards as President
Kymanox, a leader in accelerating innovation in modern medicine, announces that Evan Edwards has been promoted to President….
Let’s Talk Risk
5 Tips for Integrating Risk Management into Your QMS To Prepare for Quality Management System Regulation…
Challenges Of Concentrating and Ultra-High Concentrating Protein Therapeutics
To Improve the Patient Experience and Reduce Manufacturing Cost…
Kymanox Unveils Product Design, Development, and Commercialization Group Under Leadership of Chief Technology Officer
New C-Level Led Group Positions Kymanox as a Leader Accelerating Modern Medicine Innovation…
Kymanox Named as Winner of 2023 Triangle Business Journal Fast 50 Award
Leading global life science professional services organization is committed to continued growth because patients deserve better…
Kymanox Announces First Fellow Position
New Position of Honor for Distinguished Kymanox Clinical and Regulatory, Affairs Lead…
WestView Capital Partners Completes Growth Recapitalization Investment in Kymanox
Kymanox investment latest in WestView’s portfolio of companies providing outsourced services to life science companies….
What is the Kymanox “Ideal Knowledge Transfer™”?
Bringing Planning, Engineering, and Quality Systems Together for Reliable Outcomes…